Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.
Volunteers for NTAD study © DPUK / Shutterstock
Researchers are using mathematical modelling techniques to understand the best ways to run clinical trials for dementia

The scientists are evolving advanced mathematical models to develop a ‘clinical trials simulator’ – a computational model, based on long-term and detailed ‘cohort’ data. The models will help the scientists understand how to design clinical trials for drugs that target the earliest stages of the disease. By using cohort data – which stretches back decades in many cases – the joint university-industry team, will be able to look back in time at the development of disease. They’ll use this information to refine and optimise the design of clinical trials, ready for the next breakthrough.

You might also be interested in

Power to the people: involving the public in finding a treatment for dementia

Five members of the public, all committed to the fight against dementia, recently joined us round the table in London. They shared with us their perspectives of what is critical for volunteers to know before joining research studies. We discovered that clear communication around data security and the volunteer’s control over their contribution is vital to build trust.